NO179436C - Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk - Google Patents

Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk

Info

Publication number
NO179436C
NO179436C NO884123A NO884123A NO179436C NO 179436 C NO179436 C NO 179436C NO 884123 A NO884123 A NO 884123A NO 884123 A NO884123 A NO 884123A NO 179436 C NO179436 C NO 179436C
Authority
NO
Norway
Prior art keywords
topical use
manufacture
pharmaceutical products
proteins
stabilised
Prior art date
Application number
NO884123A
Other languages
English (en)
Norwegian (no)
Other versions
NO884123L (no
NO884123D0 (no
NO179436B (no
Inventor
Traute Mundorf
Kurt Schnecker
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO884123D0 publication Critical patent/NO884123D0/no
Publication of NO884123L publication Critical patent/NO884123L/no
Publication of NO179436B publication Critical patent/NO179436B/no
Publication of NO179436C publication Critical patent/NO179436C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO884123A 1987-09-17 1988-09-16 Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk NO179436C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873731255 DE3731255A1 (de) 1987-09-17 1987-09-17 Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen

Publications (4)

Publication Number Publication Date
NO884123D0 NO884123D0 (no) 1988-09-16
NO884123L NO884123L (no) 1989-03-20
NO179436B NO179436B (no) 1996-07-01
NO179436C true NO179436C (no) 1996-10-09

Family

ID=6336244

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884123A NO179436C (no) 1987-09-17 1988-09-16 Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk

Country Status (20)

Country Link
EP (1) EP0307857B1 (fi)
JP (1) JP2783552B2 (fi)
KR (1) KR970008112B1 (fi)
AT (1) ATE126063T1 (fi)
AU (1) AU615473B2 (fi)
CA (1) CA1329121C (fi)
DD (1) DD274562A5 (fi)
DE (2) DE3731255A1 (fi)
DK (1) DK516288A (fi)
ES (1) ES2077559T3 (fi)
FI (1) FI95770C (fi)
GR (1) GR3017432T3 (fi)
HU (1) HU203045B (fi)
IE (1) IE70908B1 (fi)
IL (1) IL87778A (fi)
NO (1) NO179436C (fi)
NZ (1) NZ226209A (fi)
PT (1) PT88539B (fi)
RU (1) RU2093145C1 (fi)
ZA (1) ZA886903B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
AU2011250139B2 (en) 2010-05-04 2015-12-10 Viscogel Ab Chitosan composition
KR20230031370A (ko) * 2017-06-12 2023-03-07 레이크우드 아메덱스, 인크. 비스포스포신 겔 제제 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5413223A (en) * 1977-07-01 1979-01-31 Ricoh Co Ltd Printer unit
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
SE8204382L (sv) * 1981-07-21 1983-01-22 Hayashibara Biochem Lab Sett att framstella malcellysfaktor och anvendning derav
CA1190148A (en) * 1981-10-13 1985-07-09 Samuel S. Asculai Interferon-containing compositions
JPS5892622A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロン安定配合製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5910524A (ja) * 1982-07-08 1984-01-20 Toray Ind Inc インタ−フエロン組成物およびその製造法
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like

Also Published As

Publication number Publication date
PT88539B (pt) 1992-11-30
FI884240A0 (fi) 1988-09-15
DE3731255A1 (de) 1989-04-06
NO884123L (no) 1989-03-20
FI95770B (fi) 1995-12-15
ES2077559T3 (es) 1995-12-01
HUT47436A (en) 1989-03-28
IL87778A0 (en) 1989-03-31
KR970008112B1 (ko) 1997-05-21
EP0307857B1 (de) 1995-08-09
CA1329121C (en) 1994-05-03
DK516288D0 (da) 1988-09-16
JPH01102029A (ja) 1989-04-19
NO884123D0 (no) 1988-09-16
AU2231688A (en) 1989-03-23
NZ226209A (en) 1991-06-25
JP2783552B2 (ja) 1998-08-06
RU2093145C1 (ru) 1997-10-20
PT88539A (pt) 1988-10-01
IE882812L (en) 1989-03-17
KR890004719A (ko) 1989-05-09
FI884240A (fi) 1989-03-18
AU615473B2 (en) 1991-10-03
ZA886903B (en) 1990-05-30
HU203045B (en) 1991-05-28
IE70908B1 (en) 1997-01-15
DD274562A5 (de) 1989-12-27
ATE126063T1 (de) 1995-08-15
EP0307857A1 (de) 1989-03-22
GR3017432T3 (en) 1995-12-31
IL87778A (en) 1993-05-13
NO179436B (no) 1996-07-01
DK516288A (da) 1989-03-18
FI95770C (fi) 1996-03-25
DE3854290D1 (de) 1995-09-14

Similar Documents

Publication Publication Date Title
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
ATE91903T1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
DK653688D0 (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
ZA885192B (en) Pharmaceutical preparations
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO179436C (no) Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO912142D0 (no) Foradditiv for fisk.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
NO881884D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
NO883932L (no) Fremgangsmaate for fremstilling av terapeutisk aktive laktamderivater.

Legal Events

Date Code Title Description
MK1K Patent expired